Article
Influence of UGT1A1 polymorphisms on the outcome of acute myeloid leukemia patients treated with cytarabine-base regimens.
Journal of translational medicine - 17 Jul 2018
Chen Peng, Zhu Ke-Wei, Zhang Dao-Yu, Yan Han, Liu Han, Liu Yan-Ling, Cao Shan, Zhou Gan, Zeng Hui, Chen Shu-Ping, Zhao Xie-Lan, Yang Jing, Chen Xiao-Ping
Abstract excerpt
BACKGROUNDS: UDP-glucuronosyltransferase 1A subfamily (UGT1A) enzymes can inactivate cytarabine (Ara-C) by glucuronidation, and thus serves as candidate genes for interindividual difference in Ara-C response. UGT1A1 is a major UGT1A isoform expressed in human liver. METHODS: UGT1A1*6 and *28 polymorphisms resulting in reduced UGT1A1 activity were genotyped in 726 adult acute myeloid leukemia (AML) patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
